Siu LL - Search Results

1

A Phase I study of cyclin-dependent kinase inhibitor, AT7519, in patients with advanced cancer: NCIC Clinical Trials Group IND 177.

Chen EX, Hotte S, Hirte H, Siu LL, Lyons J, Squires M, Lovell S, Turner S, McIntosh L, Seymour L. Chen EX, et al. Among authors: siu ll. Br J Cancer. 2014 Dec 9;111(12):2262-7. doi: 10.1038/bjc.2014.565. Epub 2014 Nov 13. Br J Cancer. 2014. PMID: 25393368 Free PMC article. Clinical Trial.

2

Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors.

Patnaik A, Warner E, Michael M, Egorin MJ, Moore MJ, Siu LL, Fracasso PM, Rivkin S, Kerr I, Litchman M, Oza AM. Patnaik A, et al. Among authors: siu ll. J Clin Oncol. 2000 Nov 1;18(21):3677-89. doi: 10.1200/JCO.2000.18.21.3677. J Clin Oncol. 2000. PMID: 11054441 Clinical Trial.

3

A National Cancer Institute of Canada clinical trials group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer.

Knowling M, Browman G, Siu L, Khoo K, Cooke A, Tannock I, Klaassen D, Cripps C, Goss G, Matthews S, Clarke R, Seymour L. Knowling M, et al. Ann Oncol. 2001 Jul;12(7):919-22. doi: 10.1023/a:1011141530545. Ann Oncol. 2001. PMID: 11521795 Free article. Clinical Trial.

4

Phase I and pharmacokinetic study of novel L-nucleoside analog troxacitabine given as a 30-minute infusion every 21 days.

Bélanger K, Moore M, Baker SD, Dionne J, Maclean M, Jolivet J, Siu L, Soulières D, Wainman N, Seymour L. Bélanger K, et al. J Clin Oncol. 2002 May 15;20(10):2567-74. doi: 10.1200/JCO.2002.12.047. J Clin Oncol. 2002. PMID: 12011137 Clinical Trial.

5

Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma.

Ma BB, Tannock IF, Pond GR, Edmonds MR, Siu LL. Ma BB, et al. Among authors: siu ll. Cancer. 2002 Dec 15;95(12):2516-23. doi: 10.1002/cncr.10995. Cancer. 2002. PMID: 12467065 Free article.

6

Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group.

Townsley CA, Chi K, Ernst DS, Belanger K, Tannock I, Bjarnason GA, Stewart D, Goel R, Ruether JD, Siu LL, Jolivet J, McIntosh L, Seymour L, Moore MJ; National Cancer Institute of Canada-Clinical Trials Group. Townsley CA, et al. Among authors: siu ll. J Clin Oncol. 2003 Apr 15;21(8):1524-9. doi: 10.1200/JCO.2003.03.057. J Clin Oncol. 2003. PMID: 12697876 Clinical Trial.

7

Phase I study of cisplatin, irinotecan, and epirubicin administered every 3 weeks in patients with advanced solid tumours.

Chen X, Oza AM, Kusenda Z, Yi QL, Kochman D, Moore MJ, Davis AJ, Siu LL. Chen X, et al. Among authors: siu ll. Br J Cancer. 2003 Aug 18;89(4):617-24. doi: 10.1038/sj.bjc.6601147. Br J Cancer. 2003. PMID: 12915867 Free PMC article. Clinical Trial.

8

A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancers.

MacKenzie MJ, Hirte HW, Siu LL, Gelmon K, Ptaszynski M, Fisher B, Eisenhauer E. MacKenzie MJ, et al. Among authors: siu ll. Ann Oncol. 2004 Apr;15(4):665-70. doi: 10.1093/annonc/mdh133. Ann Oncol. 2004. PMID: 15033677 Free article. Clinical Trial.

9

Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status.

Bahl M, Siu LL, Pond GR, Kim J, Tannock IF, Bayley A, Cummings BJ, Waldron J, Ringash J, Chen EX, Gitterman L, Lemon B, O'Sullivan B. Bahl M, et al. Among authors: siu ll. Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1127-36. doi: 10.1016/j.ijrobp.2004.05.011. Int J Radiat Oncol Biol Phys. 2004. PMID: 15519784

10

Simultaneous determination of OSI-774 and its major metabolite OSI-420 in human plasma by using HPLC with UV detection.

Zhang W, Siu LL, Moore MJ, Chen EX. Zhang W, et al. Among authors: siu ll. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jan 5;814(1):143-7. doi: 10.1016/j.jchromb.2004.10.016. J Chromatogr B Analyt Technol Biomed Life Sci. 2005. PMID: 15607718

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

432 results

Search Page